Johnson & Johnson Pauses Phase 3 COVID-19 Vaccine Trial Following ‘Unexplained Illness’
Story Highlights Weeks after Johnson & Johnson announced that their experimental COVID-19 vaccine was in final, Phase 3 testing, the company has paused the study to evaluate an unexplained illness in a study participant. AstraZeneca’s late-stage vaccine trial is also still on pause in the U.S. after two cases of a neurological illness arose in […]
Volunteer Describes His Serious Reaction in Moderna’s mRNA COVID-19 Vaccine Trial
Of the 45 volunteers in biotechnology company Moderna, Inc.’s Phase 1 human clinical trial on its experimental mRNA-1273 vaccine for COVID-19, only the names of the first two participants have been widely publicized—Jennifer Haller of Seattle, Washington and Neal Browning of Bothell, Washington. The clinical trial began on Mar. 16, 2020 at Kaiser Permanente Washington […]
Executive Order Creates Influenza Vaccine Task Force to Promote “National Security and Public Health”
On Sept. 19, 2019, President Donald Trump signed an Executive Order, “Modernizing Influenza Vaccines in the United State to Promote National Security and Public Health.” Describing mass use of influenza vaccines “to combat seasonal flu” and influenza pandemics as “strengthening our Nation’s public health and security,” he announced the establishment of a National Influenza Vaccine […]
